D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 401–500 of 1,013
Brami‐Cherrier, K., Roze, E., Girault, J., Betuing, S., & Caboche, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05879.x · Cited by 148
Curran, E. J., & Watson, S. J. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903610106 · Cited by 148
Activation of Direct and Indirect Pathway Medium Spiny Neurons Drives Distinct Brain-wide Responses
Lee, H. J., Weitz, A. J., Bernal‐Casas, D., Duffy, B. A., Choy, M., Kravitz, A. V., Kreitzer, A. C., & Lee, J. H. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.010 · Cited by 148
MacDonald, H. J., Kleppe, R., Szigetvari, P. D., & Haavik, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492126 · Cited by 148
Klockgether, T., & Turski, L. (1993) · Annals of Neurology · doi:10.1002/ana.410340413 · Cited by 147
Planert, H., Berger, T. K., & Silberberg, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057054 · Cited by 146
Dopamine modulates neural networks involved in effort-based decision-making
Assadi, S. M., Yücel, M., & Pantelis, C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.010 · Cited by 147
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors
Guigoni, C., Aubert, I., Li, Q., Gurevich, V. V., Benovic, J., Ferry, S., Mach, U., Stark, H., Leriche, L., Håkansson, K., et al. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.11.005 · Cited by 146
How do the basal ganglia regulate sleep–wake behavior?
Lazarus, M., Huang, Z., Lu, J., Urade, Y., & Chen, J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.07.001 · Cited by 146
Ariano, M. A., & Sibley, D. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)91052-9 · Cited by 146
Self-citationDevelopment of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
Thiele, S. L., Warre, R., & Nash, J. E. (2012) · Journal of Visualized Experiments · doi:10.3791/3234 · Cited by 111
Kokane, S. S., & Perrotti, L. I. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00074 · Cited by 145
Pinna, A., Chiara, G. D., Wardas, J., & Morelli, M. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01285.x · Cited by 145
Yung, K. K. L., Smith, A. D., Levey, A. I., & Bolam, J. P. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01573.x · Cited by 128
Matsuda, T., Matsuura, M., Ohkubo, T., Ohkubo, H., Matsushima, E., Inoue, K., Taira, M., & Kojima, T. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2003.12.007 · Cited by 144
Ingham, C. A., Hood, S. H., van Maldegem, B., Weenink, A., & Arbuthnott, G. W. (1993) · Experimental Brain Research · doi:10.1007/bf00227776 · Cited by 144
“Enkephalin, gamma-aminobutyric acid (GABA) and related messenger RNAs are increased, whereas substance P, dynorphin and related messenger RNAs are decreased (Young et al. 1986; Sivam et al. 1987; Vernier et al. 1988; Lindefors et al. 1989a,1990; Gerfen et al. 1990,1991 ).”
BackgroundControlled cortical impact injury affects dopaminergic transmission in the rat striatum
Wagner, A. K., Sokoloski, J. E., Ren, D., Chen, X., Khan, A. S., Zafonte, R. D., Michael, A. C., & Dixon, C. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03382.x · Cited by 144
Muthuraman, M., Koirala, N., Ciolac, D., Pintea, B., Glaser, M. B., Groppa, S. A., Tamás, G., & Groppa, S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00711 · Cited by 144
A Spatiomolecular Map of the Striatum
Märtin, A., Calvigioni, D., Tzortzi, O., Fuzik, J., Wärnberg, E., & Meletis, K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.096 · Cited by 136
Bari, A., & Pierce, R. C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.048 · Cited by 144
Liu, X., Sullivan, K. A., Madl, J. E., Legare, M. E., & Tjalkens, R. B. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj150 · Cited by 144
Dopaminergic modulation of striatal neurons, circuits, and assemblies
Surmeier, D. J., Carrillo-Reid, L., & Bargas, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.051 · Cited by 143
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1688-3 · Cited by 143
Bordet, R., Ridray, S., Schwartz, J.-C., & Sokoloff, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00089.x · Cited by 143
Cox, C. J., Sharma, M., Leckman, J. F., Zuccolo, J., Zuccolo, A., Kovoor, A., Swedo, S. E., & Cunningham, M. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1102592 · Cited by 142
Picconi, B., Bagetta, V., Ghiglieri, V., Paillé, V., Filippo, M. D., Pendolino, V., Tozzi, A., Giampà, C., Fusco, F. R., Sgobio, C., et al. (2010) · Brain · doi:10.1093/brain/awq342 · Cited by 142
Task‐specific Dystonias: A Review
Torres‐Russotto, D., & Perlmutter, J. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.012 · Cited by 141
Herrero, M. T., Augood, S. J., Hirsch, É. C., Javoy-Agid, F., Luquín, M. R., Agid, Y., Obeso, J. A., & Emson, P. C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00120-8 · Cited by 141
Does the difference between physically active and couch potato lie in the dopamine system?
Knab, A. M., & Lightfoot, J. T. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.133 · Cited by 140
Li, P., Rial, D., Canas, P. M., Yoo, J.-H., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.182 · Cited by 140
Dopamine’s Effects on Corticostriatal Synapses during Reward-Based Behaviors
Bamford, N. S., Wightman, R. M., & Sulzer, D. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.006 · Cited by 140
Rubin, J. E., McIntyre, C. C., Turner, R. S., & Wichmann, T. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08108.x · Cited by 140
Mean-field modeling of the basal ganglia-thalamocortical system. II
van Albada, S. J., Gray, R. T., Drysdale, P. M., & Robinson, P. A. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.12.013 · Cited by 140
Walters, J. R., Hu, D., Itoga, C. A., Parr‐Brownlie, L. C., & Bergstrom, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.006 · Cited by 140
Nadjar, A., Gerfen, C. R., & Bézard, E. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.013 · Cited by 140
Self-citationDopamine receptors in a songbird brain
Kubikova, L., Wada, K., & Jarvis, E. D. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22255 · Cited by 139
Georges, F., Stinus, L., Bloch, B., & Moine, C. L. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00462.x · Cited by 139
Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
Navarro, G., Moreno, E., Bonaventura, J., Brugarolas, M., Farré, D., Aguinaga, D., Mallol, J., Cortés, A., Casadó, V., Lluís, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061245 · Cited by 139
Differential Modulation of Excitatory and Inhibitory Striatal Synaptic Transmission by Histamine
Ellender, T. J., Huerta-Ocampo, I., Deisseroth, K. A., Capogna, M., & Bolam, J. P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3144-11.2011 · Cited by 138
Gold, S. J., Hoang, C. V., Potts, B. W., Porras, G., Pioli, E. Y., Kim, K. W., Nadjar, A., Qin, C., LaHoste, G. J., Li, Q., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4223-07.2007 · Cited by 138
Correa, M., Wisniecki, A., Betz, A. J., Dobson, D., O‘Neill, M. F., O’Neill, M. J., & Salamone, J. D. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00178-5 · Cited by 138
Henry, B., Fox, S. H., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7727 · Cited by 138
Surmeier, D. J., & Kitai, S. T. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)61354-0 · Cited by 138
Conventional and new antidepressant drugs in the elderly
Gareri, P., Falconi, U., Fazio, P. D., & Sarro, G. D. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00050-7 · Cited by 138
Altered D1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates
Guigoni, C., Doudnikoff, E., Li, Q., Bloch, B., & Bezard, E. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.001 · Cited by 137
Tejeda, H. A., Wu, J., Kornspun, A. R., Pignatelli, M., Kashtelyan, V., Krashes, M. J., Lowell, B. B., Carlezon, W. A., & Bonci, A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.005 · Cited by 137
Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2AAdenosine Receptors
Fredduzzi, S., Moratalla, R., Monopoli, A., Cuéllar, B., Xu, K., Ongini, E., Impagnatiello, F., Schwarzschild, M. A., & Chen, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01054.2002 · Cited by 137
Kull, B., Ferré, S., Arslan, G., Svenningsson, P., Fuxé, K., Owman, C., & Fredholm, B. B. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00184-7 · Cited by 137
What has been learnt from study of dopamine receptors in Parkinson's disease?
Hurley, M. J., & Jenner, P. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.001 · Cited by 137
Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons
Badiani, A., Oates, M. M., Day, H. E. W., Watson, S. J., Akil, H., & Robinson, T. E. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00041-8 · Cited by 137
New roles for the external globus pallidus in basal ganglia circuits and behavior
Gittis, A. H., Berke, J. D., Bevan, M. D., Chan, C. S., Mallet, N., Morrow, M. M., & Schmidt, R. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3252-14.2014 · Cited by 136
Defective Motor Behavior and Neural Gene Expression in RIIβ-Protein Kinase A Mutant Mice
Brandon, E. P., Logue, S. F., Adams, M. R., Qi, M., Sullivan, S. P., Matsumoto, A. M., Dorsa, D. M., Wehner, J. M., McKnight, G. S., & Idzerda, R. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03639.1998 · Cited by 136
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 136
Jamwal, S., & Kumar, P. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180302115032 · Cited by 128
Gritton, H. J., Howe, W. M., Romano, M. F., DiFeliceantonio, A. G., Kramer, M., Saligrama, V., Bucklin, M. E., Zemel, D., & Han, X. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0341-3 · Cited by 136
Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors
Jung, M.-Y., Skryabin, B. V., Arai, M., Abbondanzo, S. J., Fu, D., Brosius, J., Robakis, N. K., Polites, H. G., Pintar, J. E., & Schmauss, C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00705-2 · Cited by 136
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9105-4 · Cited by 136
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90832-r · Cited by 136
Deconstructing behavioral neuropharmacology with cellular specificity
Shields, B. C., Kahuno, E., Kim, C., Apostolides, P. F., Brown, J., Lindo, S., Mensh, B. D., Dudman, J. T., Lavis, L. D., & Tadross, M. R. (2017) · Science · doi:10.1126/science.aaj2161 · Cited by 135
“We first tested DART in acute striatal slices from D1-cre or D2-cre mice injected with a credependent HaloTagTM virus, thereby restricting expression to D1 or D2 cells (5, 7, 46).”
BackgroundMethodAdenosine A2A receptors in Parkinson’s disease treatment
Cieślak, M., Komoszyński, M., & Wojtczak, A. (2008) · Purinergic Signalling · doi:10.1007/s11302-008-9100-8 · Cited by 135
Computational models of basal-ganglia pathway functions: focus on functional neuroanatomy
Schroll, H., & Hamker, F. H. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00122 · Cited by 134
Reward, interrupted: Inhibitory control and its relevance to addictions
Jentsch, J. D., & Pennington, Z. T. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.022 · Cited by 134
Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms
Chase, T. N., Oh, J. D., & Konitsiotis, S. (2000) · Journal of Neurology · doi:10.1007/pl00007759 · Cited by 134
Self-citationRadja, F., Descarries, L., Dewar, K. M., & Reader, T. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90995-y · Cited by 134
Svenningsson, P., Lindskog, M., Rognoni, F., Fredholm, B. B., Greengard, P., & Fisone, G. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00510-1 · Cited by 134
Deurwaerdère, P. D., Giovanni, G. D., & Millan, M. J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.002 · Cited by 133
Klug, J. R., Engelhardt, M. D., Cadman, C. N., Li, H., Smith, J. B., Ayala, S., Williams, E. W., Hoffman, H., & Jin, X. (2018) · eLife · doi:10.7554/elife.35657 · Cited by 120
Grundmann, K., Reischmann, B., Vanhoutte, G., Hübener‐Schmid, J., Teismann, P., Hauser, T. K., Bonin, M., Wilbertz, J. H., Horn, S. V., Nguyen, H. P., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.015 · Cited by 133
The role of DARPP-32 in the actions of drugs of abuse
Nairn, A. C., Svenningsson, P., Nishi, A., Fisone, G., Girault, J., & Greengard, P. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.010 · Cited by 133
Keefe, K. A., & Gerfen, C. R. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00024-d · Cited by 133
Self-citationCalon, F., Birdi, S., Rajput, A. H., Hornykiewicz, O., Bédard, P. J., & Paolo, T. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.2.186 · Cited by 133
Molecular Characteristics of Mammalian Dopamine Receptors
Lachowicz, J. E., & Sibley, D. R. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00039.x · Cited by 132
Self-citationMolecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype
Rivera, A., Alberti, I., Martín, A. B., Narváez, J. A., De La Calle, A., & Moratalla, R. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02280.x · Cited by 132
Walton, M. E., Groves, J., Jennings, K. A., Croxson, P. L., Sharp, T., Rushworth, M. F. S., & Bannerman, D. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06726.x · Cited by 132
Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen
Werme, M., Thorén, P., Olson, L., & Brené, S. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00147.x · Cited by 132
Yan, C., Bentley, J. K., Sonnenburg, W. K., & Beavo, J. A. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-03-00973.1994 · Cited by 132
Transsynaptic Control of Gene Expression
Armstrong, R. C., & Montminy, M. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000313 · Cited by 132
Anderzhanova, E., Kirmeier, T., & Wotjak, C. T. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.03.003 · Cited by 131
Molecular substrates of action control in cortico-striatal circuits
Shiflett, M. W., & Balleine, B. W. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.007 · Cited by 110
Perreault, M. L., Hasbi, A., O’Dowd, B. F., & George, S. R. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00031 · Cited by 130
Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors
Nieh, E. H., Kim, S.-Y., Namburi, P., & Tye, K. M. (2013) · Brain Research · doi:10.1016/j.brainres.2012.11.001 · Cited by 130
A competitive model for striatal action selection
Bariselli, S., Fobbs, W. C., Creed, M. C., & Kravitz, A. V. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.009 · Cited by 130
Albertson, D. N., Schmidt, C. J., Kapatos, G., & Bannon, M. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301089 · Cited by 129
Dopamine Modulates Excitability of Spiny Neurons in the Avian Basal Ganglia
Ding, L., & Perkel, D. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05210.2002 · Cited by 119
Hársing, L. G., & Zigmond, M. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00475-7 · Cited by 129
Opposing Role for Egr3 in Nucleus Accumbens Cell Subtypes in Cocaine Action
Chandra, R., Francis, T. C., Konkalmatt, P., Amgalan, A., Gancarz, A. M., Dietz, D. M., & Lobo, M. K. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0548-15.2015 · Cited by 128
Intrinsic and integrative properties of substantia nigra pars reticulata neurons
Zhou, F., & Lee, C. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.061 · Cited by 128
Sleep disturbances in Parkinson's disease: The contribution of dopamine in REM sleep regulation
Lima, M. M. S. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.10.006 · Cited by 128
Reward and aversion processing by input-defined parallel nucleus accumbens circuits in mice
Zhou, K., Xu, H. Z., Lu, S., Jiang, S., Hou, G., Deng, X., He, M., & Zhu, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-33843-3 · Cited by 129
Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study
van Vugt, J. P. P., Siesling, S., Vergeer, M., van der Velde, E. A., & Roos, R. A. C. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.35 · Cited by 128
A Brief History of Pallidotomy
Guridi, J., & Lozano, A. M. (1997) · Neurosurgery · doi:10.1097/00006123-199711000-00029 · Cited by 128
Murer, M. G., Riquelme, L. A., Tseng, K. Y., & Pazo, J. H. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<278::aid-syn2>3.0.co;2-9 · Cited by 128
Engber, T. M., Boldry, R. C., Kuo, S., & Chase, T. N. (1992) · Brain Research · doi:10.1016/0006-8993(92)90716-m · Cited by 128
Self-citationDARPP-32, Jack of All Trades? Master of Which?
Yger, M., & Girault, J. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00056 · Cited by 127
Young, K. A., Gobrogge, K. L., & Wang, Z. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.004 · Cited by 113
Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons
Lester, J., Fink, S., Aronin, N., & DiFiglia, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90303-5 · Cited by 127
Output architecture of the primate putamen
Flaherty, A., & Graybiel, A. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03222.1993 · Cited by 126
Abnormal bidirectional plasticity-like effects in Parkinson's disease
Huang, Y.-Z., Rothwell, J. C., Lu, C.-S., Chuang, W.-L., & Chen, R.-S. (2011) · Brain · doi:10.1093/brain/awr158 · Cited by 126
Convergent evidence for abnormal striatal synaptic plasticity in dystonia
Peterson, D. A., B, T. J. S. A., & Poizner, H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.003 · Cited by 126
Kato, M., Miyashita, N., Hikosaka, O., Matsumura, M., Usui, S., & Kori, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00912.1995 · Cited by 119
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.